Cargando…

Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease

INTRODUCTION: Immune correlates of protection afforded by PHV02, a recombinant vesicular stomatitis (rVSV) vector vaccine against Nipah virus (NiV) disease, were investigated in the African green monkey (AGM) model. Neutralizing antibody to NiV has been proposed as the principal mediator of protecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monath, Thomas P., Nichols, Richard, Feldmann, Friederike, Griffin, Amanda, Haddock, Elaine, Callison, Julie, Meade-White, Kimberly, Okumura, Atsushi, Lovaglio, Jamie, Hanley, Patrick W., Clancy, Chad S., Shaia, Carl, Rida, Wasima, Fusco, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507387/ https://www.ncbi.nlm.nih.gov/pubmed/37731485 http://dx.doi.org/10.3389/fimmu.2023.1216225

Ejemplares similares

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
por: Zhu, Wenjun, et al.
Publicado: (2022)

Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential
por: Monath, Thomas P., et al.
Publicado: (2022)

Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine
por: DeBuysscher, Blair L, et al.
Publicado: (2016)

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease
por: Mire, Chad E, et al.
Publicado: (2013)

Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
por: Woolsey, Courtney, et al.
Publicado: (2023)

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015)

High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
por: Morozov, Igor, et al.
Publicado: (2021)

A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades
por: Furuyama, Wakako, et al.
Publicado: (2020)

Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
por: Mire, Chad E., et al.
Publicado: (2019)

Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques
por: Marzi, Andrea, et al.
Publicado: (2023)

Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine
por: Furuyama, Wakako, et al.
Publicado: (2022)

A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein
por: Kaku, Yoshihiro, et al.
Publicado: (2009)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
por: Suder, Ellen, et al.
Publicado: (2018)

The synthetic futures of vesicular stomatitis virus
por: Overend, Christopher, et al.
Publicado: (2012)

Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters
por: Baseler, Laura, et al.
Publicado: (2016)

Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2014)

EFFECT OF FORMALIN ON THE VIRUS OF VESICULAR STOMATITIS OF HORSES
por: Olitsky, Peter K., et al.
Publicado: (1928)

Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein
Publicado: (1979)

Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model
por: de Wit, Emmie, et al.
Publicado: (2022)

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
por: Mire, Chad E., et al.
Publicado: (2013)

ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys
por: van Doremalen, Neeltje, et al.
Publicado: (2022)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
por: Cham, Lamin B., et al.
Publicado: (2019)

Effect of sulfhydryl reagents on the infectivity of vesicular stomatitis virus
por: Beatrice, Sara T., et al.
Publicado: (1980)

TRIM69 Inhibits Vesicular Stomatitis Indiana Virus
por: Rihn, Suzannah J., et al.
Publicado: (2019)

Atomic model of vesicular stomatitis virus and mechanism of assembly
por: Zhou, Kang, et al.
Publicado: (2022)

Emerging Biomedical Applications of the Vesicular Stomatitis Virus Glycoprotein
por: Rehman, Sheeba, et al.
Publicado: (2022)

Long-Term Single-Dose Efficacy of a Vesicular Stomatitis Virus-Based Andes Virus Vaccine in Syrian Hamsters
por: Prescott, Joseph, et al.
Publicado: (2014)

Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors
por: Slough, Megan M., et al.
Publicado: (2019)

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
por: Nagalo, Bolni Marius, et al.
Publicado: (2020)

COMPARATIVE STUDIES ON THE VIRUSES OF VESICULAR STOMATITIS AND EQUINE ENCEPHALOMYELITIS (1)
por: Olitsky, Peter K., et al.
Publicado: (1934)

Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses
Publicado: (1981)

Structure of the Vesicular Stomatitis Virus N(0)-P Complex
por: Leyrat, Cédric, et al.
Publicado: (2011)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
por: Bishnoi, Suman, et al.
Publicado: (2018)

Evaluating Temperature Sensitivity of Vesicular Stomatitis Virus–Based Vaccines
por: Stein, Derek R., et al.
Publicado: (2019)

Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors
por: Rozo-Lopez, Paula, et al.
Publicado: (2018)

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
por: Clarke, David K., et al.
Publicado: (2006)

Venereal Transmission of Vesicular Stomatitis Virus by Culicoides sonorensis Midges
por: Rozo-Lopez, Paula, et al.
Publicado: (2020)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
por: Liu, Guodong, et al.
Publicado: (2021)

Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?
por: Zhang, Yuguo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_70b70seqjvj3sedd6dndrh2ra5